165 related articles for article (PubMed ID: 37735184)
1. FAT4 expression in peripheral blood mononuclear cells is associated with prognosis and immune cell infiltration in hepatocellular carcinoma.
Li J; Lv M; Huang Q; Hu R; Zhong X; Sun X; Feng W; Han Z; Ma M; Zhang W; Zhou X
Sci Rep; 2023 Sep; 13(1):15735. PubMed ID: 37735184
[TBL] [Abstract][Full Text] [Related]
2. Targeted genomic profiling identifies frequent deleterious mutations in FAT4 and TP53 genes in HBV-associated hepatocellular carcinoma.
Huang FY; Wong DK; Tsui VW; Seto WK; Mak LY; Cheung TT; Lai KK; Yuen MF
BMC Cancer; 2019 Aug; 19(1):789. PubMed ID: 31395065
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of ZC3H13 by miR-362-3p/miR-425-5p is associated with a poor prognosis and adverse outcomes in hepatocellular carcinoma.
Wu S; Liu S; Cao Y; Chao G; Wang P; Pan H
Aging (Albany NY); 2022 Mar; 14(5):2304-2319. PubMed ID: 35278064
[TBL] [Abstract][Full Text] [Related]
4. A pan-cancer analysis of FAT atypical cadherin 4 (FAT4) in human tumors.
Mao W; Zhou J; Hu J; Zhao K; Fu Z; Wang J; Mao K
Front Public Health; 2022; 10():969070. PubMed ID: 36051999
[TBL] [Abstract][Full Text] [Related]
5. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma.
Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q
Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157
[TBL] [Abstract][Full Text] [Related]
6. Inferring the progression of multifocal liver cancer from spatial and temporal genomic heterogeneity.
Shi JY; Xing Q; Duan M; Wang ZC; Yang LX; Zhao YJ; Wang XY; Liu Y; Deng M; Ding ZB; Ke AW; Zhou J; Fan J; Cao Y; Wang J; Xi R; Gao Q
Oncotarget; 2016 Jan; 7(3):2867-77. PubMed ID: 26672766
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-199b-5p attenuates TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
Zhou SJ; Liu FY; Zhang AH; Liang HF; Wang Y; Ma R; Jiang YH; Sun NF
Br J Cancer; 2017 Jul; 117(2):233-244. PubMed ID: 28588321
[TBL] [Abstract][Full Text] [Related]
8. Identification of immune-related target and prognostic biomarkers in PBMC of hepatocellular carcinoma.
Hu R; Zhang W; Han Z; Ma M; Huang Q; Lv M; Ma W; Sun X; Feng W; Li J; Zhong X; Sun J; Yao W; Zhou X
BMC Gastroenterol; 2023 Jul; 23(1):234. PubMed ID: 37438735
[TBL] [Abstract][Full Text] [Related]
9. hsa-miR-9-5p-Mediated TSPAN9 Downregulation Is Positively Related to Both Poor Hepatocellular Carcinoma Prognosis and the Tumor Immune Infiltration.
Tan S; Song X; Zhang C; Sun Y; Zhang J; Zhang Z; Zhang R; Zhang T; Zhu X; Tan H
J Immunol Res; 2022; 2022():9051229. PubMed ID: 35600044
[TBL] [Abstract][Full Text] [Related]
10. Identification of MiR-211-5p as a tumor suppressor by targeting ACSL4 in Hepatocellular Carcinoma.
Qin X; Zhang J; Lin Y; Sun XM; Zhang JN; Cheng ZQ
J Transl Med; 2020 Aug; 18(1):326. PubMed ID: 32859232
[TBL] [Abstract][Full Text] [Related]
11. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma.
Zhang X; Ma L; Zhai L; Chen D; Li Y; Shang Z; Zhang Z; Gao Y; Yang W; Li Y; Pan Y
Int J Med Sci; 2021; 18(4):984-999. PubMed ID: 33456356
[TBL] [Abstract][Full Text] [Related]
12. Roles of the miR-139-5p/CCT5 axis in hepatocellular carcinoma: a bioinformatic analysis.
Xu J; Zhang Y; Liu C; Yan P; Yang Z
Int J Med Sci; 2021; 18(15):3556-3564. PubMed ID: 34522182
[No Abstract] [Full Text] [Related]
13. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
[TBL] [Abstract][Full Text] [Related]
14. Circular RNA expression profiles of peripheral blood mononuclear cells in hepatocellular carcinoma patients by sequence analysis.
Lei B; Zhou J; Xuan X; Tian Z; Zhang M; Gao W; Lin Y; Ni B; Pang H; Fan W
Cancer Med; 2019 Apr; 8(4):1423-1433. PubMed ID: 30714679
[TBL] [Abstract][Full Text] [Related]
15. MiR-877-5p suppresses cell growth, migration and invasion by targeting cyclin dependent kinase 14 and predicts prognosis in hepatocellular carcinoma.
Yan TH; Qiu C; Sun J; Li WH
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3038-3046. PubMed ID: 29863248
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-183-5p contributes to malignant progression through targeting PDCD4 in human hepatocellular carcinoma.
Duan X; Li W; Hu P; Jiang B; Yang J; Zhou L; Mao X; Tian B
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33078826
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.
Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY
J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of miR-1266-5p serves as a prognostic biomarker of hepatocellular carcinoma and facilitates tumor cell proliferation, migration and invasion.
Su Y; Xie R; Xu Q
Acta Biochim Pol; 2021 May; 68(2):293-300. PubMed ID: 34006084
[TBL] [Abstract][Full Text] [Related]
19. Dual targeting of PD-L1 and PD-L2 by PCED1B-AS1 via sponging hsa-miR-194-5p induces immunosuppression in hepatocellular carcinoma.
Fan F; Chen K; Lu X; Li A; Liu C; Wu B
Hepatol Int; 2021 Apr; 15(2):444-458. PubMed ID: 33219943
[TBL] [Abstract][Full Text] [Related]
20. miR-106b-5p promotes aggressive progression of hepatocellular carcinoma via targeting RUNX3.
Gu H; Gu S; Zhang X; Zhang S; Zhang D; Lin J; Hasengbayi S; Han W
Cancer Med; 2019 Nov; 8(15):6756-6767. PubMed ID: 31503422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]